Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - LA JOLLA PHARMACEUTICAL CO | c15518e10vk.htm |
| EX-31.2 - EXHIBIT 31.2 - LA JOLLA PHARMACEUTICAL CO | c15518exv31w2.htm |
| EX-21.1 - EXHIBIT 21.1 - LA JOLLA PHARMACEUTICAL CO | c15518exv21w1.htm |
| EX-32.1 - EXHIBIT 32.1 - LA JOLLA PHARMACEUTICAL CO | c15518exv32w1.htm |
| EX-31.1 - EXHIBIT 31.1 - LA JOLLA PHARMACEUTICAL CO | c15518exv31w1.htm |
| EX-23.2 - EXHIBIT 23.2 - LA JOLLA PHARMACEUTICAL CO | c15518exv23w2.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
La Jolla Pharmaceutical Company
San Diego, California
San Diego, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 Nos.
333-106060, 333-116233, 333-125427, 333-131248, 333-143677, 333-151825 and 333-169140 of La Jolla
Pharmaceutical Company of our report dated April 13, 2011, relating to the consolidated financial
statements, which appear in the Annual Report on Form 10-K. Our report contains an explanatory
paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, LLP
San Diego, California
San Diego, California